Could a Team-Based approach improve life for lung disease patients?
NCT ID NCT06626438
First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 27 times
Summary
This trial tests whether a personalized 'treatable traits' care model—where patients see a lung specialist, physiotherapist, psychologist, and dietitian together—can improve quality of life and slow disease progression in people with interstitial lung disease. About 110 participants will be randomly assigned to either this team-based care or standard care. The study measures quality of life, symptoms, exercise capacity, and survival without progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASES (ILD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fiona Stanley Hospital
RECRUITINGPerth, Western Australia, 6150, Australia
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sir Charles Gairdner Hospital
NOT_YET_RECRUITINGPerth, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
treatable traits model of care (multidisciplinary clinic with doctor, physiotherapist, psychologist, dietitian)
What this could lead to
If it works, this could show that personalized, team-based care improves quality of life and slows disease progression for people with interstitial lung disease.
What could go wrong
This is a relatively small, early-stage trial testing a care model rather than a drug, so results may not be dramatic or widely applicable. The intervention is complex and may not be easy to implement in other settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.